Tag:
Anika Therapeutics
Latest Headlines
Latest Headlines
Genzyme hits Anika with patent suit
Genzyme ( NASDAQ: GENZ ) is hauling Anika Therapeutics ( NASDAQ: ANIK ) to court in Massachusetts over the latter's proposed osteoarthritis treatment Monovisc, which could be approved by the FDA in the
Anika shares skyrocket on Canadian drug approval
Shares of Anika Therapeutics soared as much as 62 percent this morning after the Bedford, MA-based developer announced that its osteoarthritis therapy won marketing approval in Canada. Monovisc
